Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Screening Emotions in Adolescents Receiving Care at the Hospital for mild Traumatic Brain Injury (SEARCH-mTBI): protocol for a multicenter observational study.

BMC pediatrics·2026
Same author

Response to the Letter to the Editor Regarding "Presentation and Diagnosis of Spondylolysis".

Pediatric emergency care·2026
Same author

Pediatric Post-Tonsillectomy Hemorrhage Management: A Cross-Sectional Otolaryngology and Emergency Medicine Survey.

Laryngoscope investigative otolaryngology·2026
Same author

Implementing an Education Intervention for Prescription Opioid Pain Medication at Pediatric Trauma Centers.

Substance use & misuse·2026
Same author

The impact of COVID-19 on patterns of burns evaluated in pediatric emergency departments.

Burns : journal of the International Society for Burn Injuries·2025
Same author

Comparing injury severity scores from trauma registries with those mapped from injury diagnosis codes in injured adolescents.

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention·2025

Related Experiment Video

Updated: Jun 6, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Pediatric psychotropic polypharmacy.

Mark R Zonfrillo, Joseph V Penn, Henrietta L Leonard

    Psychiatry (Edgmont (Pa. : Township))
    |December 15, 2010
    PubMed
    Summary
    This summary is machine-generated.

    Pediatric psychotropic polypharmacy, the use of multiple psychiatric medications, is increasing. More research is needed to understand the risks and benefits of these combined treatments in children.

    Related Experiment Videos

    Last Updated: Jun 6, 2026

    Guidelines for Elective Pediatric Fiberoptic Intubation
    11:19

    Guidelines for Elective Pediatric Fiberoptic Intubation

    Published on: January 17, 2011

    Area of Science:

    • Pediatric Psychiatry
    • Clinical Pharmacology
    • Evidence-Based Medicine

    Background:

    • Psychotropic polypharmacy involves prescribing multiple medications for psychiatric conditions in children.
    • Understanding the prevalence and trends of this practice is crucial for child mental health.
    • Limited data exists on the specific rates within the pediatric population.

    Purpose of the Study:

    • To assess the rates of psychotropic polypharmacy in pediatric populations.
    • To review existing literature on the prevalence of prescribing multiple psychotropic medications to children.
    • To identify trends and common medication combinations.

    Main Methods:

    • A comprehensive literature review was conducted.
    • Articles were sourced from the PubMed database.
    • The search focused on pediatric populations (under 18) from 1994 to April 2004.

    Main Results:

    • While exact rates varied, all reviewed studies indicated an increasing trend in psychotropic polypharmacy over time.
    • The most common combination involved stimulant medications with other psychotropic drugs.
    • Data was gathered from diverse pediatric clinical settings.

    Conclusions:

    • Available data suggests a rise in psychotropic polypharmacy among children.
    • This trend raises concerns due to potential increases in adverse events.
    • Further systematic research is essential to understand efficacy, side effects, and optimal prescribing practices.